News Results
There are 982,024 News Results
Sep 20, 2018
SAN MATEO, Calif., Sept. 20, 2018 /PRNewswire/ -- GoPro, Inc. (NASDAQ: GPRO) today announced its new product lineup including its $399 flagship, HERO7 Black, which sets a new bar for...
Sep 25, 2018
SCOTTSDALE, AZ, Sept. 25, 2018 /PRNewswire/ - At its annual customer conference today, Saba Software , the talent development company, unveiled its hyper-connected talent development roadmap, featuring new innovations and...
Sep 27, 2018
CHICAGO, Sept. 27, 2018 /PRNewswire/ -- (PRINT, Epson Booth #3121)
Oct 5, 2018
SPRINGFIELD, Mass. and BURLINGTON, Vt., Oct. 5, 2018 /PRNewswire/ -- Expanding its relationship with the University of Vermont's (UVM) Complex Systems Center, Massachusetts Mutual Life Insurance Company (MassMutual) announced today...
Oct 8, 2018
General Micro Systems (GMS) today introduced the industry’s first rugged, conduction-cooled, commercial off-the-shelf (COTS) deep learning/artificial intelligence (AI) mobile system that offers real-time data analysis and decision making directly on...
Oct 31, 2018
MIAMI, Oct. 31, 2018 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), the world's largest leisure travel company, today announced that the U.S. Patent and Trademark Office (USPTO)...
Oct 31, 2018
SAN ANTONIO, Oct. 31, 2018 /PRNewswire/ -- Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for...
Nov 2, 2018
ANN ARBOR, Mich., Nov. 2, 2018 /PRNewswire/ -- Hospitals and health systems at the forefront of using healthcare IT to improve the delivery of care have maximized the benefits of...
Nov 12, 2018
MONMOUTH JUNCTION, N.J., Nov. 12, 2018 /PRNewswire/ -- Tris Pharma, Inc. (Tris), a biopharmaceutical company focused on developing innovative products that deliver meaningful patient benefits, today announced that it presented...
Nov 13, 2018
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2018 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), today announced that the U.S. Food and Drug Administration (FDA) has concluded their 30-day review of...